Abstract
AIM: To examine strains of Pseudomonas aeruginosa for specific antifungal factors. METHODS: Two clinical strains of P aeruginosa with strong in vitro inhibition (by cross streak assay) of Candida albicans and Aspergillus fumigatus were examined. Both strains were isolated from sputum--one from a patient with cystic fibrosis and one from a patient with bronchiectasis. Bacterial extracts were fractionated by high performance liquid chromatography and examined by ultraviolet absorbance and mass spectroscopy. Antifungal activity against C albicans and A fumigatus was determined in a well plate assay. RESULTS: Pyocyanin was the major antifungal agent of P aeruginosa; 1-hydroxy-phenazine also possessed activity. Pyocyanin MICs for C albicans and A fumigatus were > 64 micrograms/ml. These phenazines were active against nine other yeast species pathogenic for man. Preliminary experiments also suggested possible inhibition of yeast mycelial transformation in C albicans by pyocyanin. CONCLUSIONS: There may be a role for pyocyanin and 1-hydroxyphenazine in the prevention of pulmonary candidiasis in patients colonised by P aeruginosa.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Costa A. L., Cusumano V. Attivita' antimicotica della piocianina in vitro ed in vivo su di um ceppo patogeno di Candida albicans. G Batteriol Virol Immunol Microbiol. 1973 Jul-Dec;66(7-12):297–308. [PubMed] [Google Scholar]
- Hughes W. T., Kim H. K. Mycoflora in cystic fibrosis: some ecologic aspects of Pseudomonas aeruginosa and Candida albicans. Mycopathol Mycol Appl. 1973 Jul 31;50(3):261–269. doi: 10.1007/BF02053377. [DOI] [PubMed] [Google Scholar]
- Kanthakumar K., Taylor G., Tsang K. W., Cundell D. R., Rutman A., Smith S., Jeffery P. K., Cole P. J., Wilson R. Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro. Infect Immun. 1993 Jul;61(7):2848–2853. doi: 10.1128/iai.61.7.2848-2853.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kerr J. R. Suppression of fungal growth exhibited by Pseudomonas aeruginosa. J Clin Microbiol. 1994 Feb;32(2):525–527. doi: 10.1128/jcm.32.2.525-527.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kerr J. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. J Infect. 1994 May;28(3):305–310. doi: 10.1016/s0163-4453(94)91943-7. [DOI] [PubMed] [Google Scholar]
- Knight M., Hartman P. E., Hartman Z., Young V. M. A new method of preparation of pyocyanin and demonstration of an unusual bacterial sensitivity. Anal Biochem. 1979 May;95(1):19–23. doi: 10.1016/0003-2697(79)90179-9. [DOI] [PubMed] [Google Scholar]
- Niimi M. Dibutyryl cyclic AMP-enhanced germ tube formation in exponentially growing Candida albicans cells. Fungal Genet Biol. 1996 Mar;20(1):79–83. doi: 10.1006/fgbi.1996.0013. [DOI] [PubMed] [Google Scholar]
- Ras G. J., Anderson R., Taylor G. W., Savage J. E., Van Niekerk E., Wilson R., Cole P. J. Proinflammatory interactions of pyocyanin and 1-hydroxyphenazine with human neutrophils in vitro. J Infect Dis. 1990 Jul;162(1):178–185. doi: 10.1093/infdis/162.1.178. [DOI] [PubMed] [Google Scholar]
- Wilson R., Pitt T., Taylor G., Watson D., MacDermot J., Sykes D., Roberts D., Cole P. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest. 1987 Jan;79(1):221–229. doi: 10.1172/JCI112787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilson R., Sykes D. A., Watson D., Rutman A., Taylor G. W., Cole P. J. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun. 1988 Sep;56(9):2515–2517. doi: 10.1128/iai.56.9.2515-2517.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]